<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Virbac survey finds canine mast cell tumours may be under-diagnosed</title><link>/b/veterinary-nursing-news/posts/virbac-survey-finds-canine-mast-cell-tumours-may-be-under-diagnosed</link><description> Virbac, maker of Stelfonta, has released the result of a quick poll of vets at the London Vet Show who said that on average, they had diagnosed 7.03 mast cell tumours (MCTs) in the last year, when earlier research had showed the figure should be more</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>